Jesup & Lamont downgrades Draxis Health (Nasdaq: DRAX) to Neutral, citing a favorable buyout agreement by Jubilant.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE